Post-marketing experience of vedolizumab: Pneumonia and other respiratory tract infections
| Main Authors: | , , |
|---|---|
| Format: | Conference item |
| Published: |
BMJ Publishing Group
2017
|
| _version_ | 1797085278056218624 |
|---|---|
| author | Bhayat, F Blake, A Travis, S |
| author_facet | Bhayat, F Blake, A Travis, S |
| author_sort | Bhayat, F |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T02:06:38Z |
| format | Conference item |
| id | oxford-uuid:9f3ab08e-c2c6-41dd-a5be-731268e95d63 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T02:06:38Z |
| publishDate | 2017 |
| publisher | BMJ Publishing Group |
| record_format | dspace |
| spelling | oxford-uuid:9f3ab08e-c2c6-41dd-a5be-731268e95d632022-03-27T00:55:45ZPost-marketing experience of vedolizumab: Pneumonia and other respiratory tract infectionsConference itemhttp://purl.org/coar/resource_type/c_5794uuid:9f3ab08e-c2c6-41dd-a5be-731268e95d63Symplectic Elements at OxfordBMJ Publishing Group2017Bhayat, FBlake, ATravis, S |
| spellingShingle | Bhayat, F Blake, A Travis, S Post-marketing experience of vedolizumab: Pneumonia and other respiratory tract infections |
| title | Post-marketing experience of vedolizumab: Pneumonia and other respiratory tract infections |
| title_full | Post-marketing experience of vedolizumab: Pneumonia and other respiratory tract infections |
| title_fullStr | Post-marketing experience of vedolizumab: Pneumonia and other respiratory tract infections |
| title_full_unstemmed | Post-marketing experience of vedolizumab: Pneumonia and other respiratory tract infections |
| title_short | Post-marketing experience of vedolizumab: Pneumonia and other respiratory tract infections |
| title_sort | post marketing experience of vedolizumab pneumonia and other respiratory tract infections |
| work_keys_str_mv | AT bhayatf postmarketingexperienceofvedolizumabpneumoniaandotherrespiratorytractinfections AT blakea postmarketingexperienceofvedolizumabpneumoniaandotherrespiratorytractinfections AT traviss postmarketingexperienceofvedolizumabpneumoniaandotherrespiratorytractinfections |